Sr. Director, Nonclinical Safety & Portfolio Strategy at AbbVie — NeverHard

Job Description Description: AbbVie’s Development Biological Sciences department is seeking a Senior Director for its Portfolio Leadership Group. This pivotal leadership role will serve as a nonclinical safety representative for assigned molecules across AbbVie’s diverse portfolio. As a safety representative, the Senior Director will be responsible for the overall strategy and execution of the nonclinical toxicology program, collaborating cross-functionally with project leads, providing data interpretation at various internal and external venues, and authoring regulatory documents. The ideal candidate will have 15+ years of experience in the area of non-clinical safety within the pharmaceutical industry. He/she should have the experience and ability to develop drug candidates from discovery through marketing. This senior-level position is expected to have a high impact contributing scientific expertise in nonclinical safety assessment, knowledge of industry best practices and pertinent regulatory guidelines, and a vision of future enhancements in the field. Responsibilities: Drive the strategic vision and direction for nonclinical safety, influencing key R&D and portfolio decisions at the organizational level. Serve as an active member for multi-disciplinary project teams as a nonclinical safety functional area subject matter expert. Articulate and communicate non-clinical safety strategies and provide development plans for multiple drug modalities including but not limited to small molecules, biologics, ADCs, and/or cell and gene therapies, across various therapeutic areas including but not limited to oncology, neuroscience, and immunology. Participate in due diligence reviews of drug products to identify potential risks and provide recommendations for partnership or in-licensing. Author and submit regulatory documents (IBs, INDs/CTAs, NDAs/BLAs, regulatory queries) and interact with regulatory agencies (US and ex-US) as needed. Generate impurity, excipient and metabolite risk assessments as necessary during the life cycle of a drug candidate. Lead, mentor and develop others as it pertains to drug development and the execution of the portfolio, with an emphasis on the nonclinical aspects. Participation in pharmaceutical industry consortia related to nonclinical aspects of drug development.